The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

BACKGROUND: Oxaliplatin, irinotecan, 5-fluorouracil, and l-leucovorin (FOLFIRINOX) has become one of the first-line treatment options for advanced pancreatic cancer (PC). However, the relatively high rate of grade 3 or 4 adverse events associated with the standard dosage of FOLFIRINOX limits its wid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Commun (Lond)
Main Authors: Wang, Zhi-Qiang, Zhang, Fei, Deng, Ting, Zhang, Le, Feng, Fen, Wang, Feng-Hua, Wang, Wei, Wang, De-Shen, Luo, Hui-Yan, Xu, Rui-Hua, Ba, Yi, Li, Yu-Hong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507030/
https://ncbi.nlm.nih.gov/pubmed/31068222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-019-0367-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados